通化东宝：2025年上半年实现营收13.73亿元，房地产行业实现营收185.57万元|财面儿

Group 1 - Company achieved revenue of 1.373 billion yuan, representing a year-on-year growth of 85.60% [1] - Company reported a net profit attributable to shareholders of 218 million yuan [1] - Company operates in the pharmaceutical manufacturing industry, focusing on drug research, production, and sales [1] Group 2 - Pharmaceutical industry revenue reached 1.354 billion yuan, up from 723 million yuan in the same period last year [1] - Real estate industry revenue was 1.8557 million yuan, compared to 906,300 yuan in the same period last year [1]